SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001193125-20-317069
Filing Date
2020-12-14
Accepted
2020-12-14 16:59:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A d800199dsctoia.htm SC TO-I/A 21254
  Complete submission text file 0001193125-20-317069.txt   22873
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filed by) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-90534 | Film No.: 201386885
SIC: 2834 Pharmaceutical Preparations